111, Inc. (YI) Stock Forecast

NASDAQ: YIAnalyst ratings, price target and estimates.

YI analyst forecast

as of October 18, 2026
Analyst consensus
—
Price target
$5.96
average of analyst targets
Upside to target
+90.4%
from the latest close
Next earnings
—
52-week range
$2.56 – $8.38

YI price target

Price $3.13Target $5.96
52-week low $2.5652-week high $8.38

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

YI earnings per share estimates

111, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Next fiscal year (2026)$0.00$0.00$0.00———

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

YI revenue estimates

111, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Next fiscal year (2026)$16.75B$16.75B$16.75B+9.9%1

YI EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

YI revenue: reported and forecast

Reported revenueEstimate (average; low–high)

YI EPS estimate revisions

111, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Next fiscal year (2026)$0.00$0.00$0.00$0.00$0.00—0 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

YI earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; YI beat in 1 of 1.

What analysts expect from YI

The average price target is $5.96, 90.4% above the latest close of $3.13. For 2026 the average estimate is $0.00 per share on revenue of $16.7 billion. 111 beat the EPS estimate in 1 of the last 1 quarters.

Related: YI income statement, YI key metrics, YI chart. See the YI stock overview for the latest quote and news.

YI forecast FAQ

What is 111's price target?

The average analyst price target for 111 is $5.96, 90.4% above the latest close of $3.13.

Does 111 usually beat earnings estimates?

111 reported EPS at or above the analyst estimate in 1 of the last 1 quarters.

Medical Distribution: forecast